Please ensure Javascript is enabled for purposes of website accessibility

Why Repro Med Stock Is Sinking Today

By Keith Speights - Jan 26, 2021 at 11:14AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The unexpected departure of the company's CEO appears to have rattled investors.

What happened

Shares of Repro Med Systems (KRMD 1.45%), which conducts its business as KORU Medical, were sinking 13.4% as of 11 a.m. EST on Tuesday. The decline came after the specialty infusions solutions company provided an update after the market closed on Monday. KORU gave preliminary financial results for full-year 2020. It also announced the immediate resignation of Don Pettigrew as president and CEO. 

So what

Any time a company's CEO departs unexpectedly, investors become nervous. Pettigrew had led Repro Med/KORU Medical for nearly two years. The company's board of directors named former home infusion executive and KORU Medical board member Jim Beck as interim CEO.

Man wearing a suit looking at a red line crashing through the floor

Image source: Getty Images.

This news overshadowed the company's preliminary 2020 results. Revenue is expected to come in at around $24 million, up 3.4% year over year. This figure is well under the average analyst estimate of $25.9 million.

There were several factors that weighed on the company's revenue last year. International sales and clinical trial partnerships didn't meet expectations in the second half of 2020. The COVID-19 pandemic negatively impacted new patient starts. KORU also experienced major fluctuations in demand due to buying patterns of several large customers. In addition, the company's revenue grew more slowly than anticipated last year as a result of what KORU referred to as "strengthening of our contractual position with large customers."

Now what

Could a positive catalyst be on the way for the healthcare stock after today's big drop? It isn't likely that KORU's fourth-quarter update scheduled for March will help very much considering the company's full-year 2020 preliminary results. The company's board will actively search for a new CEO, but that probably won't help boost its share price much either. What KORU mainly needs is solid sales growth. Investors might have to wait at least until the first-quarter update later this year to see if the company can deliver.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Repro Med Systems, Inc. Stock Quote
Repro Med Systems, Inc.
$2.10 (1.45%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.